Blackstone, Carlyle consortium reach deal to buy Medline

2 minute read

The ticker and trading information for Blackstone Group is displayed at the post where it is traded on the floor of the New York Stock Exchange (NYSE) April 4, 2016. REUTERS/Brendan McDermid

Register now for FREE unlimited access to Reuters.com

June 5 (Reuters) - A consortium of three private equity firms, including Blackstone Group Inc (BX.N) and Carlyle Group (CG.O), have signed a definitive agreement to buy a majority stake in medical supplier Medline Industries Inc, sources familiar with the matter have told Reuters.

The deal values Medline at more than $30 billion, excluding debt, the sources said. Medline has an enterprise value of about $34 billion, including borrowings, the sources said.

Medline's current management and founding family, led by Chief Executive Charles Mills, will remain the company's largest single shareholder when the deal is expected to close in the second half of this year, the sources said.

Register now for FREE unlimited access to Reuters.com

The three buyout firms buying majority of Medline are Blackstone, Carlyle and Hellman & Friedman. The Government of Singapore Investment Corporation (GIC) is also investing in Medline as part of the deal.

Northfield, Illinois-based Medline is one of the largest privately-held manufacturers and distributors of medicals supplies such as surgical equipment, gloves, and laboratory devices used by hospitals around the world. The company generated $17.5 billion in revenue in 2020, according to its website.

The Wall Street journal first reported about the transaction.

Register now for FREE unlimited access to Reuters.com
Reporting by Sabahatjahan Contractor in Bengaluru; editing by Diane Craft

Our Standards: The Thomson Reuters Trust Principles.